Introduction {#Sec1}
============

In vivo two-photon imaging is an analytical approach that can be used to visualize cell dynamics and hemodynamics in organs or tissues of live animals. Information in real time obtained by using this approach, such as changes in cell behavior and morphology, tissue localization, and blood flow, has revealed highly sophisticated and dynamic systems of living organisms. During in vivo imaging, the blood circulation in the tissue being observed is maintained; therefore, this technique is also effective for analyzing the migration and invasion of immune cells in the inflammatory environment. Observations in physiological environments deepen our understanding of host response mechanisms under both steady-state and disease conditions.

Computed tomography, X-ray, and IVIS Spectrum (an in vivo imaging system) imaging methods have been used as non-invasive approaches; however, these techniques have low spatiotemporal resolution and have been able to estimate only the site of inflammation in an organ^[@CR1],[@CR2]^. Therefore, it is impossible to observe cellular responses of the immune system using these approaches. By contrast, a two-photon excitation laser microscope, the light source of which is a near-infrared laser that produces low damage to cells but has long-reaching depth in tissue, enables us to capture the movement of cells in living animals at high resolution. Two-photon imaging has been in use in biological science since the 1990s; it has progressed at a remarkable rate, and observation methods for various organs, including brain, liver, and lymph nodes, have been reported^[@CR3],[@CR4]^. In this protocol, we describe how to use it to image virus-infected lungs. We have previously demonstrated that this protocol works by using mice infected with mouse-adapted seasonal influenza virus (H1N1) or highly pathogenic avian influenza virus (H5N1)^[@CR5]^.

Challenges when imaging the lung {#Sec2}
--------------------------------

The lung, which is a respiratory organ, has contact with the outside environment and is an important organ for research on immunity to infectious diseases. In the seventeenth century, Marcello Malpighi discovered pulmonary capillaries and alveoli in the frog lung by using optical microscopy^[@CR6]^; now fluorescent reporter mice facilitate the study of disease models in conjunction with two-photon excitation microscopy (Table [1](#Tab1){ref-type="table"}). However, a challenge encountered when imaging the lung is that it is constantly moving during respiration. The lung has been stabilized in several ways during in vivo observation by microscopy, including bronchus clamping, prolonged apnea, gluing, and suction^[@CR7],[@CR8]^; however, it is difficult to reduce motion artifacts due to lung respiratory movement under physiological conditions and hence to obtain high-quality images. Bronchus clamping can suppress respiratory motion artifacts of the lung lobe^[@CR9],[@CR10]^; however, it is not suitable for long-term observation because it causes severe hypoxia. Although prolonging apnea is less invasive^[@CR11]--[@CR13]^, it does not allow researchers sufficient time to observe the lung for image acquisition by two-photon excitation microscopy, and the quality of the images tends to deteriorate over time. Gluing addresses the above limitations^[@CR14],[@CR15]^; however, it can induce shear force injury and inflammation, which affect the interpretation of results. A suction window, which is currently the most commonly used stabilizing system during lung imaging, achieves moderate immobilization of the lung and high-quality images^[@CR16]--[@CR19]^; however, the observation period is limited to ≤12 h. Ex vivo imaging of lungs and in vivo imaging of trachea have also been performed as complementary methods^[@CR8]^. Each of these methods has its advantages and disadvantages, and it is important to select and optimize the method best suited to the goal of the experiments and disease model.Table 1Summary of the disease and experimental models used for in vivo microscopic observation of the lungDisease/experimental modelTechniqueAnimal modelYearRef.Disease/experimental modelTechniqueAnimal modelYearRef.Steady stateClampingCats, rabbits1925^[@CR48]^HypoxiaSuctionDogs1975^[@CR49]^Window approachCats1926^[@CR50]^SuctionDogs1979^[@CR51]^Manual trackingDogs, frogs, alligators1930^[@CR52]^SuctionDogs1981^[@CR53]^ClampingRabbits, cats, dogs1933^[@CR9]^SuctionDogs1982^[@CR54]^Window approach/curareCats1934^[@CR55]^SuctionRabbits1992^[@CR56]^SuctionCats1939^[@CR57]^Prolonged apneaMice2008^[@CR12]^Window approachDogs1965^[@CR58]^Prolonged apneaMice2013^[@CR59]^SuctionDogs1969^[@CR60]^Ischemia--reperfusion injuryProlonged apneaRats1999^[@CR11]^SuctionDogs1982^[@CR61]^Prolonged apneaRats1999^[@CR62]^SuctionDogs1987^[@CR63]^GlueMice2010^[@CR14]^Window approach/pancuroniumRabbits1989^[@CR64]^GlueMice2011^[@CR65]^SuctionDogs1992^[@CR66]^GlueMice2015^[@CR15]^SuctionRabbits1993^[@CR67]^GlueMice2017^[@CR68]^SuctionRabbits1994^[@CR69]^LPS inoculationProlonged apneaMice2012^[@CR70]^SuctionDogs1994^[@CR71]^SuctionMice2014^[@CR72]^SuctionDogs1995^[@CR73]^SuctionMice2016^[@CR74]^Prolonged apneaRabbits1997^[@CR75]^SuctionMice2017^[@CR76]^Prolonged apneaRabbits1999^[@CR77]^SuctionMice2019^[@CR78]^SuctionRabbits2002^[@CR79]^Cecal ligation and punctureSuctionRats2000^[@CR80]^SuctionRats2005^[@CR81]^SuctionMice2018^[@CR82]^Prolonged apneaMice2013^[@CR83]^SuctionMice2019^[@CR78]^SuctionMice2017^[@CR19]^Allergen challengeUltra-thin stick objectiveMice2008^[@CR84]^Bacterial infectionGlueMice2010^[@CR14]^ClampingMice2010^[@CR10]^Prolonged apneaMice2013^[@CR85]^SuctionMice2012^[@CR86]^Motion correctionMice2014^[@CR87]^SuctionMice2019^[@CR88]^Prolonged apneaMice2014^[@CR13]^Sickle cell diseaseSuctionMice2014^[@CR89]^Prolonged apneaMice2016^[@CR90]^SuctionMice2017^[@CR76]^SuctionMice2016^[@CR91]^Oleic acid inoculationWindow approachRats1994^[@CR92]^SuctionMice2017^[@CR93]^Hyperthermia/hypothermia/hypovolemia/hypoventilationProlonged apneaRats2001^[@CR94]^SuctionMice2017^[@CR95]^Acid inoculationProlonged apneaMice2009^[@CR96]^SuctionMice2018^[@CR97]^Phorbol 12--myristate 13--acetate inoculationSuctionRats2011^[@CR17]^SuctionMice2018^[@CR98]^Heparinase inoculationProlonged apneaMice2012^[@CR70]^SuctionMice2018^[@CR99]^Cytokine inoculationSuctionMice2013^[@CR100]^Viral infectionSuctionMice2018^[@CR5]^TransfusionSuctionMice2015^[@CR101]^Tumor metastasisSuctionMice2000^[@CR102]^Thermal hepatic injurySuctionMice2017^[@CR103]^SuctionMice2015^[@CR104]^FibrosisSuctionMice2019^[@CR105]^SuctionMice2015^[@CR106]^Cytokine inoculationSuctionMice2019^[@CR107]^SuctionMice2016^[@CR108]^SuctionMice2016^[@CR18]^SuctionMice2016^[@CR109]^GlueMice2018^[@CR110]^

In vivo observation of lungs has been performed using various lung disease and experimental models, including bacterial infection, allergen inoculation, tumor metastasis, and lipopolysaccharide (LPS)-induced sepsis (Table [1](#Tab1){ref-type="table"}). However, for viral respiratory diseases, such as influenza, other than an observation in a methodology report^[@CR20]^, only analyses of the trachea in vivo^[@CR21]--[@CR23]^ and isolated lungs had been performed^[@CR24]^, with no analysis of the lung in vivo, until our recent publication^[@CR5]^ (Table [1](#Tab1){ref-type="table"}). Unlike ex vivo methods, which involve isolated or sliced lungs, in vivo imaging using two-photon excitation microscopy of live animals enables researchers to observe hemodynamics, migration and extravasation of immune cells, as well as interactions among immune cells during influenza virus infection. However, it is technically demanding to perform two-photon excitation microscopy of live influenza virus--infected lung, which exhibits severe inflammation, requiring the development of highly sophisticated, less invasive instruments and surgical techniques. In addition, when observing animals infected with pathogenic viruses, specialized facilities and instruments are frequently required to avoid the spread of the virus. Furthermore, because many types of immune cells infiltrate the infected lung in an inflammatory environment, it is necessary to distinguish the target immune cells from the infected cells by using fluorescent labels in the infected microenvironment. To detect multiple fluorescent signals excited simultaneously by a two-photon excitation laser, fluorochromes with different spectra and equal brightness must be selected; however, there is currently no comprehensive database of fluorescent reagents, fluorescent reporter viruses, and reporter mouse lines available for lung in vivo imaging. We therefore also provide a database of fluorescent dyes, antibodies, and reporter mouse lines that can be used in combination with a reporter influenza virus (Color-flu)^[@CR25]--[@CR27]^ for multicolor analysis under pathological conditions in this protocol.

Our system uses suction-based lung stabilization^[@CR16],[@CR28]^ to improve an existing in vivo two-photon imaging system for influenza virus--infected lung as a model of an acute inflammatory respiratory disease^[@CR5]^. We have successfully used C57BL/6 mice and transgenic mice of the C57BL/6 background (6- to 10-week-old males and females). By using our method, described in detail here, it is possible to visualize and analyze the behavior of immune cells and their interactions with infected cells during an influenza virus infection, which creates an acute inflammatory environment.

Limitations of the protocol {#Sec3}
---------------------------

A limitation of two-photon excitation microscopy is that the observation depth that can be achieved is a maximum of \~70 μm. Therefore, we cannot observe the bronchial region. This limitation is linked to the wavelength of the infrared laser and detector capability of the microscope. However, as laser technology develops, the observation depth achievable using this method will improve.

Applications of the protocol {#Sec4}
----------------------------

In this protocol, we describe the application of this methodology to influenza virus infection of the lungs because this is what we have used it for previously. This protocol could be applied not only to studies of the early stages of inflammation due to infection or other causes, but also to analyses of tissue regeneration mechanisms in lungs that are in the process of recovering from infection or other injuries. The information provided will also be useful to those using two-photon imaging analysis for the evaluation of the effects of drugs and vaccines, as well as biological events in the lungs and other organs (e.g., liver, spleen)^[@CR5]^. Moreover, with minor modifications, the approach could be applied to analyses of other respiratory diseases, including other infectious models (e.g., severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS)), pulmonary fibrosis, and tumor metastasis.

Materials {#Sec5}
=========

Biological materials {#Sec6}
--------------------

*Mice*. We have successfully used 6- to 10-week-old C57BL/6 mice (Japan SLC, mouse line C57BL/6JJmsSlc) and the following transgenic mouse lines: *CAG-ECFP* (cat. no. 004218), *Cd11c-DTR/GFP* (cat. no. 004509), *Zbtb46-GFP* (cat. no. 027618), *Csf1r-GFP* (cat. no. 018549), *Cx3cr1-GFP* (cat. no. 005582), *Ncr1-GFP* (cat. no. 022739), *Clec9a-GFP* (cat. no. 017696), *Sftpc-GFP* (cat. no. 028356), *Cd11c-Cre* (cat. no. 008068), *Zbtb46-Cre* (cat. no. 028538), *Cx3cr1-Cre* (cat. no. 025524), *Cx3cr1-CreER* (cat. no. 020940), *Cd8a-Cre* (cat. no. 008766), *Cd4-CreER* (cat. no. 022356), *Cd19-Cre* (cat. no. 006785), *Mcpt8-Cre* (cat. no. 017578), *loxP*-flanked *R26-tdTomato* (Ai14) (cat. no. 007914), *R26-EYFP* (cat. no. 006148), and *R26-mT/mG* (cat. no. 007676) mice, which can be obtained from the Jackson Laboratory. *CAG-Cre* mice can be obtained from J. Miyazaki (Osaka University Graduate School of Medicine)^[@CR29]^. *LysM-GFP* mice can be obtained from T. Graf (Albert Einstein College of Medicine)^[@CR30]^. *Sftpc-CreER* mice can be obtained from B.L.M. Hogan (Duke University Medical Center)^[@CR31]^. *Ly6g-Cre* (Catchup) mice can be obtained from M.G.^[@CR32]^. *R26-mTFP1* mice can be obtained from I. Imayoshi (Kyoto University)^[@CR33]^. Cre strains were bred to *R26-tdTomato*, *R26-EYFP*, *R26-mTFP1*, or *R26-mT/mG* mice. *Sftpc*^*CreER/+*^*;R26*^*tdTomato/+*^ mice, *Sftpc*^*CreER/+*^*;R26*^*mTmG/+*^ mice, *Sftpc*^*CreER/+*^*;R26*^*tdTomato/+*^*;Cx3cr1*^*GFP/+*^mice and *Cx3cr1*^*CreER/+*^*;R26*^*tdTomato/+*^ mice were intraperitoneally injected with 1 mg of tamoxifen for 5 d. *Cd4*^*CreER/+*^*;R26*^*tdTomato/+*^ mice and *Cd4*^*CreER/+*^*;R26*^*mTmG/+*^ mice were intraperitoneally injected with 5 mg of tamoxifen for 5 d**Caution**All animal care and experiments must conform to the guidelines for animal experiments of the relevant government and institution. All our animal care and experiments conformed to the guidelines for animal experiments of the University of Tokyo and were approved by the animal research committee of the University of Tokyo (PA17-31 and PA17-17).*Viruses*. We have used MA-eCFP-H5N1, MA-Cerulean-H5N1, MA-eGFP-H5N1, MA-Venus-H5N1, and MA-mCherry-H5N1 (A/Vietnam/1203/2004\[H5N1\]); and MA-eCFP-PR8, MA-Cerulean-PR8, MA-eGFP-PR8, MA-Venus-PR8, and MA-mCherry-PR8 (A/Puerto Rico/8/34\[H1N1\]), which express a fluorescent reporter protein (eCFP, Cerulean, eGFP, Venus, or mCherry) fused to the NS1 protein. Viruses were generated by using reverse genetics^[@CR25]--[@CR27]^. Virus strains should be propagated in Madin-Darby canine kidney (MDCK) cells. The MDCK cell line we used was obtained from R.G. Webster (St. Jude Children's Research Hospital). DNA fingerprinting showed that this cell line has the same origin as one obtained from ATCC (cat. no. CCL-34, RRID:CVCL_0422)**Caution**All viruses and infected animals should be handled in accordance with your institution's biosafety regulations. All work on highly pathogenic avian influenza viruses must be performed under biosafety level 3 (BSL3) regulations. Accordingly, all our in vivo imaging studies were performed in the BSL3 facility at the University of Tokyo (Tokyo, Japan), which is approved for such use by the Ministry of Agriculture, Forestry, and Fisheries of Japan**Critical**The cells should be regularly checked to ensure that they are not contaminated with mycoplasma.

Reagents {#Sec7}
--------

### Critical {#FPar4}

Although the suppliers used for all reagents are provided, alternative reagents are available in most cases. All reagents should be stored according to the manufacturer's recommendations. For aliquot sizes for reagents, see the 'Reagent setup' section.

Sterile phosphate buffered saline (PBS, pH 7.4; made in-house)Sterile saline solution (NaCl, 0.9% (wt/vol); made in-house)Dimethyl sulfoxide, sterile-filtered (DMSO; Nacalai Tesque, cat. no. 13408-64)**Caution**DMSO readily penetrates the skin; wear rubber gloves and protective eye goggles.Sunflower seed oil (Sigma-Aldrich, cat. no. 88921)Ethanol (99.5%; FujiFilm Wako Pure Chemical, cat. no. 057-00456)**Caution**Ethanol is highly flammable and may cause eye irritation. Handle it appropriately.Tamoxifen (Sigma-Aldrich, cat. no. T5648)Isoflurane (MSD Animal Health)**Caution**Isoflurane is an anesthetic gas associated with adverse health outcomes. It should be used in a well-ventilated room or with another appropriate removal system. Store it in a locked drawer at room temperature (18--25 °C).Sevoflurane (Maruishi Pharmaceutical)**Caution**Sevoflurane is an anesthetic gas associated with adverse health outcomes. It should be used in a well-ventilated room or with another appropriate removal system. Store it in a locked drawer at room temperature.

### Fluorescent reagents {#Sec8}

#### Caution {#FPar9}

Fluorescent reagents can be harmful. They should be handled according to the manufacturer's instructions while wearing proper protective clothing

#### Critical {#FPar10}

Choose fluorescent reagents as required for your experiment.

Cascade Blue-conjugated dextran (10,000 molecular weight (MW); Invitrogen, cat. no. D1976)Fluorescein isothiocyanate (FITC)-conjugated dextran (4,000 MW; Sigma-Aldrich, cat. no. 46944)FITC-conjugated dextran (10,000 MW; Invitrogen, cat. no. D1820)FITC-conjugated dextran (40,000 MW; Invitrogen, cat. no. D1845)FITC-conjugated dextran (70,000 MW; Sigma-Aldrich, cat. no. 46945)Texas Red-conjugated dextran (3,000 MW; Invitrogen, cat. no. D3328)Texas Red-conjugated dextran (10,000 MW; Invitrogen, cat. no. D1863)Texas Red-conjugated dextran (70,000 MW; Invitrogen, cat. no. D1864)Qtracker 655 vascular labels (Invitrogen, cat. no. Q21021MP)Qdot 655 wheat germ agglutinin (WGA) conjugate (Invitrogen, cat. no. Q12021MP)Calcein AM solution (Sigma-Aldrich, cat. no. C1359)SYTOX Blue nucleic acid stain (Invitrogen, cat. no. S11348)SYTOX Green nucleic acid stain (Invitrogen, cat. no. S7020)SYTOX Orange nucleic acid stain (Invitrogen, cat. no. S11368)Propidium iodide (Invitrogen, cat. no. P1304MP)DAPI (4ʹ,6-diamidino-2-phenylindole, dilactate; Invitrogen, cat. no. D3571)Hoechst 33342, trihydrochloride, trihydrate (Invitrogen, cat. no. H3570)Pan caspase (FAM-VAD-FMK) in vivo probe, green (Vergent Bioscience, cat. no. 20100)CellROX Green Reagent (Invitrogen, cat. no. C10444)CellROX Orange Reagent (Invitrogen, cat. no. C10443)CellROX Deep Red Reagent (Invitrogen, cat. no. C10422)LysoTracker Blue DND-22 (Invitrogen, cat. no. L7525)LysoTracker Green DND-26 (Invitrogen, cat. no. L7526)LysoTracker Red DND-99 (Invitrogen, cat. no. L7528)LysoTracker Deep Red (Invitrogen, cat. no. L12492)MitoTracker Orange CMTMRos (Invitrogen, cat. no. M7510)MitoTracker Red CM-H~2~Xros (Invitrogen, cat. no. M7513)MitoTracker Red FM (Invitrogen, cat. no. M22425)Rhodamine 6G (Sigma-Aldrich, cat. no. 252433)Tetramethylrhodamine, ethyl ester, perchlorate (TMRE; Invitrogen, cat. no. T669)FluoSpheres polystyrene microspheres (1.0 µm, red fluorescent; Invitrogen, cat. no. F13083)SiR-actin (Cytoskeleton, cat. no. CY-SC001)SiR-tubulin (Cytoskeleton, cat. no. CY-SC002)PKH26 Red Fluorescent Cell Linker Kit (Sigma-Aldrich, cat. no. PKH26PCL)FITC-conjugated anti-mouse Ly-6G antibody (BioLegend, cat. no. 127606, RRID: AB_1236494)Alexa Fluor 488--conjugated anti-mouse Ly-6G antibody (BioLegend, cat. no. 127626, RRID: AB_2561340)DyLight 488--conjugated anti-mouse Ly-6G antibody (Leinco Technologies, cat. no. L287, RRID: AB_2810281)PE-conjugated anti-mouse Ly-6G antibody (BD Biosciences, cat. no. 551461, RRID: AB_394208)Alexa Fluor 594--conjugated anti-mouse Ly-6G antibody (BioLegend, cat. no. 127636, RRID: AB_2563207)Alexa Fluor 647--conjugated anti-mouse Ly-6G antibody (BioLegend, cat. no. 127610, RRID: AB_1134159)

Equipment {#Sec9}
---------

Dark microtubes, (1.5 ml; Watson, cat. no. 131-915)Microsurgery straight scissors (13.5 cm; BRC, cat. no. 64152075)Microsurgery straight iris scissors (11.0 cm; BRC, cat. no. 64122001)Microsurgery hooked forceps (12.7 cm; BRC, cat. no. 64121044)Microsurgery bulldog forceps (BRC, cat. no. 70052-30CII/R)Tracheal cannula (1.1 × 32 mm; i.d., 0.80 mm; Nipro, cat. no. 09-043)Insulin syringes (0.5 ml, 100 U, 30 gauge × 10 mm; Nipro, cat. no. 08277)Pasteur pipettes (BD Falcon, cat. no. 357575)Customized surgical retractor (made in-house)Thoracic suction window (Sakura Seiki, custom made)Stage for mounting a thoracic suction window (Sakura Seiki, custom made)Suction regulator (Iwaki, cat. no. 1450050)Cover glass (Matsunami Glass, cat. no. C013001)Hot plate (Hipet, cat. no. 4977007036379)Adhesive tape (Yamato, cat. no. NO200-19)Customized microscope stage (Narishige, custom made)Confocal microscope system (Zeiss, model no. LSM 780 NLO)Infrared laser (Coherent, model no. Chameleon Vision II)20× water immersion lens (Zeiss, Plan-Apochromat model)Beam-pointing stabilizer (TEM Messtechnik, model no. Aligna 4D system)High-efficiency particulate air (HEPA) filters (Vacushield; Pall, cat. no. 4402)Artificial ventilator (Shinano, cat. no. SN-480-7)Airway pressure monitor (Shinano)Gas anesthesia vaporizer (Shinano, cat. no. SN-487-OT)Mouse anesthesia induction chamber (Shinano, cat. no. SN-487-85-02)Mouse anesthesia mask (Shinano, cat. no. SN-487-70-08)Parafilm (Laboratory & Medical Supplies, cat. no. PM-996)Positive pressure mask (Versaflo Faceshields; 3M, cat. no. TR-300-HKL and TR-3712N)Tyvek suit (DuPont, cat. no. SoftWear III)Surgical gloves (SIAM OKAMOTO, cat. no. OM-100)Small glass window (Thorlabs, cat. no. WG12012-B)Planar window, RS seal (Roxtec, cat. no. RS 100 AISI 316 woc/SLFRS 100 AISI 316)Pulse oximeter (Kent Scientific, model. no. LabOx-1)

### Software {#Sec10}

CellProfiler (Broad Institute: <https://cellprofiler.org/>)MATLAB (MathWorks: <https://www.mathworks.com/products/matlab.html>)Prism 6 software (GraphPad: <https://www.graphpad.com/scientific-software/prism/>)ImageJ (NIH: <https://imagej.nih.gov/ij/>)TrackMate^[@CR34]^, a plugin for ImageJ (NIH: <https://imagej.net/TrackMate>)

Reagent setup {#Sec11}
-------------

### Critical {#FPar11}

All reagents should be prepared under sterile conditions. Fluorescent reagents should be protecting from light during the setup procedure because they are light sensitive.

### Tamoxifen solution {#Sec12}

To prepare 10 mg/ml of tamoxifen solution in sunflower seed oil, dissolve 100 mg of tamoxifen in 1 ml of ethanol (99.5%) and add 9 ml of sunflower seed oil. After adding the ethanol and sunflower seed oil, mix well by vortexing and sonication. This solution can be stored in a refrigerator (2--8 °C) for a week.

#### Caution {#FPar12}

Tamoxifen powder should be handled in a hood. To avoid inhalation and contact with skin, wear rubber gloves and a surgical mask.

### Fluorescent dextran {#Sec13}

Prepare a solution at a concentration of 2 mg/ml in sterile 1× PBS or saline, make aliquots in 1.5-ml microtubes, and store them in a refrigerator (2--8 °C) for up to 2 weeks. Inject 50 μl (100 μg) of fluorescent dextran i.v. per mouse.

### Qtracker 655 vascular labels {#Sec14}

Immediately before use, add 5 μl of the stock solution to 95 μl of sterile 1× PBS or saline to make 100 μl total and inject 50 μl i.v. at a concentration of 0.1 μM.

### FluoSpheres polystyrene microspheres {#Sec15}

Prepare a solution at a concentration of 1 × 10^8^ beads/ml in sterile 1× PBS or saline, make aliquots of the solution in dark 1.5-ml microtubes, and store them in a refrigerator (2--8 °C) for long periods (\~3 months). Immediately before use, mix well and inject 50 μl i.v. per mouse.

### Qdot 655 WGA {#Sec16}

Immediately before use, add 5 μl of the stock solution to 95 μl of sterile 1× PBS or saline to make 100 μl total and i.v. inject 50 μl.

### Calcein AM solution {#Sec17}

Prepare a solution at a concentration of 100 μM in sterile 1× PBS or saline, dispense the solution into dark 1.5-ml microtubes, and store them in a refrigerator (2--8 °C) for up to 2 weeks. Inject 50 μl of fluorescent dextran i.v. per mouse.

### SYTOX Blue, Green, and Orange {#Sec18}

Divide the 5 mM DMSO stock solution into dark 1.5-ml microtubes and store them at −20 °C for up to 3 months. Immediately before use, prepare a solution at a concentration of 50 μM in sterile 1× PBS or saline and i.v. inject 50 μl per mouse.

### Propidium iodide {#Sec19}

Prepare a solution at a concentration of 100 mM in sterile 1× PBS or saline, dispense the solution in dark 1.5-ml microtubes, and store them at −20 °C for up to 3 months. Immediately before use, prepare a solution at a concentration of 1 mM in sterile 1× PBS or saline and inject 50 μl i.v. per mouse.

### DAPI {#Sec20}

Prepare a solution at a concentration of 10 mM in sterile 1× PBS or saline, make aliquots of the solution in dark 1.5-ml microtubes, and store them in a refrigerator (2--8 °C) for up to 2 weeks. Inject 50 μl of the solution i.v. per mouse.

### Pan caspase (FAM-VAD-FMK) in vivo probe {#Sec21}

Prepare a working solution according to the vendor's manual, dissolve pan caspase in vivo probe in 5 μl of DMSO, and add 55 μl of 1× injection buffer (from the kit). Inject 60 μl of the solution i.v. per mouse within 1 h of preparation.

### PKH26 {#Sec22}

Prepare a working solution according to the vendor's manual, dissolve 100 μl of PKH26PCL in 900 μl of ethanol and store at room temperature for up to 3 months. Immediately before use, prepare a solution at a concentration of 10 μM in sterile Dilution Buffer (from the kit) and inject 50 μl intranasally per mouse.

### CellROX Green, Orange, and Deep Red {#Sec23}

Immediately before use, add 50 μl of the stock solution to 450 μl of sterile 1× PBS or saline to make 500 μl total and inject 50 μl i.v. at a concentration of 250 μM.

### LysoTracker Blue, Green, Red, and Deep Red {#Sec24}

Immediately before use, add 50 μl of the stock solution to 450 μl of sterile 1× PBS or saline to make 500 μl total and inject 50 μl i.v. at a concentration of 100 μM.

### MitoTracker Orange CMTMRos, Red CM-H2Xros, and Red FM {#Sec25}

Immediately before use, dilute 50 μg of MitoTracker in 1 ml of DMSO and inject 50 μl i.v. at a concentration of 100 μM.

#### Critical {#FPar13}

The MitoTracker solution should be prepared fresh each time immediately before use.

### Rhodamine 6G {#Sec26}

Prepare the solution at a concentration of 10 mM in sterile 1× PBS or saline, make aliquots in dark 1.5-ml microtubes, and store them in a refrigerator (2--8 °C) for up to 2 weeks. Immediately before use, prepare a solution at a concentration of 10 μM in sterile 1× PBS or saline and inject 50 μl i.v. per mouse.

### TMRE {#Sec27}

Prepare the solution at a concentration of 10 mM in DMSO, make aliquots in dark 1.5-ml microtubes, and store them in a refrigerator (2--8 °C) for up to 2 weeks. Immediately before use, prepare a working solution at a concentration of 1 mM in sterile 1× PBS or saline and inject 50 μl i.v. per mouse.

### SiR-actin and SiR-tubulin {#Sec28}

Prepare each solution at a concentration of 1 mM in DMSO, make aliquots in dark 1.5-ml microtubes, and store them in a refrigerator (2--8 °C) for up to 1 week. Immediately before use, prepare solutions at a concentration of 100 μM in sterile 1× PBS or saline and inject 50 μl i.v. per mouse.

### Fluorescent antibody {#Sec29}

Dilute fluorescent antibodies to a concentration of 1 µg per 10 μl with sterile 1× PBS or saline and inject 50 μl i.v. per mouse.

#### Caution {#FPar14}

It should be noted that antibody staining may affect the target cell behavior; for example, at a high dose (\~200 μg), antibodies may neutralize cell activities and/or cause antibody-dependent cytotoxic activity^[@CR35]--[@CR37]^. In our studies, we use 5 µg of antibody for brightness screening because inoculation of fluorochrome-conjugated anti-Ly-6G antibody at low doses (1--40 µg) into mice does not affect neutrophil recruitment^[@CR38]^. The contribution of Ly-6G, which is expressed predominantly on murine neutrophils, to recruitment during inflammation remains a matter of debate. It has been reported that low-dose antibody treatment inhibited Ly-6G ligation and the recruitment of neutrophils to the site of inflammation^[@CR39]^; however, a more recent study indicated that Ly-6G knockout did not affect either neutrophil differentiation or recruitment to the site of inflammation in Catchup mice^[@CR32]^. Therefore, a low dose of anti-Ly-6G antibody is used in our protocol.

Equipment setup {#Sec30}
---------------

### Laser path adjustment system {#Sec31}

An overview of the laser path adjustment system is shown in Fig. [1](#Fig1){ref-type="fig"}. Our two-photon excitation laser (Chameleon Vision II) unit is placed on an anti-vibration table outside the BSL3 facility. The laser beam enters the BSL3 room, where the two-photon excitation scanning microscope is located, through a window (composed of a small glass window (WG12012-B) and a planar window (RS seal)) connecting the inside and the outside of the BSL3 facility (Fig. [1c,d](#Fig1){ref-type="fig"}). The laser path connecting the laser source unit and the two-photon excitation microscope is adjusted by automated laser beam alignment and the Aligna 4D stabilization system is adjusted with two active mirrors.Fig. 1The laser path adjustment system.**a**, Schematic image of the system for correcting the laser beam path. **b**, Layout of active mirrors to adjust the laser path. **c**, The window through which the laser connecting the inside and outside of the BSL3 facility passes. **d**, Arrangement of the two-photon excitation microscope inside the BSL3 facility and the laser unit outside the BSL3 facility. Some images provided courtesy of Coherent and Zeiss.

#### Caution {#FPar15}

This system adjusts the laser path passing from the outside to the inside of the BSL3 facility for maintenance purposes, so there is no need for this setup unless you are using pathogens that require BSL3 containment. Heat is generated when the laser source unit is running, so keep the temperature and humidity constant by using air conditioning equipment.

#### Caution {#FPar16}

The system should be operated only by users trained to deal with unenclosed high-power invisible beams and should be placed in an appropriate enclosure with interlocking doors.

### Two-photon excitation laser scanning microscopy system for in vivo imaging of virus-infected mouse lungs in a BSL3 facility {#Sec32}

A schematic of the arrangement of the in vivo lung imaging system for virus-infected mouse is shown in Fig. [2a](#Fig2){ref-type="fig"}, and layout examples are shown in Fig. [2b--g](#Fig2){ref-type="fig"}. This in vivo lung imaging system is based on the upright microscope LSM 780 NLO system, which is equipped with four different lasers (excitation at 405, 488, 543, and 633 nm) for confocal imaging and a two-photon excitation laser (excitation at 630--1,050 nm). To be able to perform the surgical procedure on the mouse, we replaced the sample stage with a large, flat one (microscope stage for in vivo experiment) as shown in Fig. [2b,c](#Fig2){ref-type="fig"}. To efficiently excite multiple fluorescent proteins and fluorescent dyes simultaneously, the wavelength of the infrared laser should be set at 910 nm. All fluorescent spectra between the 410- and 695-nm wavelengths can be detected using a 20× water immersion lens, and we record signals in lambda image stacks (0.13 frames per s, 1,024 × 1,024 pixels) and acquire *z*-stack images with *z*-depths of 5 μm (total of 10-μm *z*-depth). We perform spectral separation of the acquired lambda stacks by using the linear unmixing function of the ZEN software. Although the LSM 780 microscope system is controlled by a primary personal computer, we recommended adding \>64 GB of RAM for appropriate imaging analysis.Fig. 2The in vivo lung imaging system for virus-infected mouse.**a**, Schematic image of the imaging system for virus-infected lungs**. b**, Placement of life support devices and lung stabilizer devices. **c**, Surgical stage. **d**, Anesthesia machine and mechanical ventilator. **e**--**g**, The operator wearing a Tyvek suit and a positive-pressure mask. All our animal care and experiments conformed to the guidelines for animal experiments of the University of Tokyo and were approved by the animal research committee of the University of Tokyo (PA17-31 and PA17-17). Some images in **a** provided courtesy of Zeiss.

We keep the mice on a heated stage on the sample stage and record their vital signs using a LabOx-1 pulse oximeter. To observe the lungs of the mice with a thoracotomy, we place the ventilator with an airway pressure monitor and anesthesia machine for rodents in appropriate positions on the stage. We installed high-efficiency particulate air (HEPA) filters in the exhalation duct of the ventilation system (Fig. [2b,d](#Fig2){ref-type="fig"}), and the operator wore a positive pressure mask (Versaflo Faceshields) and a Tyvek suit (Fig. [2e--g](#Fig2){ref-type="fig"}) to avoid exposure to the viruses.

#### Caution {#FPar17}

The wavelength and power of the excitation laser should be adjusted appropriately according to the experimental conditions. Increasing the laser power enhances target signals and enables detection of second-harmonic generation (SHG), in which structures with repeating patterns lead to the formation of a signal. SHG is a useful phenomenon for visualizing collagen fibers in the lung without staining; however, it should be noted that the autofluorescence of lung tissue is also enhanced under excessive excitation conditions (Supplementary Fig. [1](#Fig7){ref-type="supplementary-material"}). When using this protocol, we did not perform experiments under which SHG occurs, in order to minimize autofluorescence; it is better to adjust the laser power according to the experimental purpose. When the wavelength of the excitation laser is too short, the autofluorescence signal becomes very strong and it is difficult to observe properly. By contrast, when the laser wavelength is too long, it becomes difficult to obtain a signal because of the short excitation energy (Supplementary Fig. [2](#Fig8){ref-type="supplementary-material"}).

#### Caution {#FPar18}

Although color separation of emission using a conventional optical band-pass filter is also available for this protocol, multispectral imaging is a useful approach for simultaneously analyzing multiple targets by eliminating tissue autofluorescence and identifying fluorescent labels with overlapping spectra^[@CR40],[@CR41]^. In vivo two-photon imaging is performed under conditions of single stimulation with a two-photon excitation laser; limitations exist regarding available fluorescent reagents/proteins for multiple labeling of target cells and lung architecture. Therefore, we recommend using a multispectral approach to produce crosstalk-free images of fluorescence with overlapping spectra that cannot be separated by using band-pass filters. Before starting experiments, it is necessary to collect spectral signatures of the emission signal of each fluorescent reagent and protein as reference spectra under the same excitation condition as will be used in the experiment.

### Thoracic suction window and surgical tools {#Sec33}

To observe the mouse lung using an upright microscope, it is necessary to prepare a thoracic suction window to immobilize the lung. In the BSL3 facility, animal experiments must be performed while wearing two or three layers of latex gloves; therefore, the thoracic suction window was designed for easy handling, even in the BSL3 facility, and to be minimally invasive for the infected animals (Fig. [3a--c](#Fig3){ref-type="fig"} and Supplementary Fig. [3](#Fig9){ref-type="supplementary-material"}). To position a cover glass for each observation, flatten the upper surface of the thoracic suction window so that a commercially available cover glass will fit. This device is also designed to reduce concavity and convexity as much as possible so that blood containing virus cannot accumulate. Connect the thoracic suction window to an aspirator through a waste tank and a suction regulator. To prevent the spread of virus-containing aerosols, install HEPA filters between the waste tank and the suction regulator as shown in Fig. [3d](#Fig3){ref-type="fig"}.Fig. 3Devices to stabilize lungs.**a**, Surgical tools**. b**, Thoracic suction window. **c**, Setup of thoracic suction window and the holding devices. **d**, Device layout pertaining to lung stabilization.

Procedure {#Sec34}
=========

Infection with fluorescent influenza viruses {#Sec35}
--------------------------------------------

Timing 10--20 minOn Day 0, intranasally inoculate C57BL/6 ('B6') mice or transgenic mice with 10^5^ plaque-forming units (PFUs) of Color-flu viruses in 50 μl of PBS under sevoflurane anesthesia. Tables [2](#Tab2){ref-type="table"} and [3](#Tab3){ref-type="table"} show the brightness levels of fluorescence of representative reporter mouse immune cells and Color-flu viruses in vivo.Table 2Comparison of fluorescent reporter mice for in vivo imaging using two-photon excitation microscopyMousePublished specificityRef.BrightnessNote*CAG*^*ECFP/ECFP*^Ubiquitous[@CR111]+++Fluorescent signals are detectable; useful*CAG*^*Cre/+*^*;R26*^*EYFP/+*^Ubiquitous[@CR29],[@CR112]+Fluorescent signals are hardly detectable*CAG*^*Cre/+*^*;R26*^*tdTomato/+*^Ubiquitous[@CR29],[@CR42]++++Fluorescent signals are very strong*CAG*^*ECFP/+*^*;R26*^*mTmG/+*^Ubiquitous[@CR111],[@CR113]++ (ECFP) ++ (mTomato)Fluorescent signals are detectable; useful*R26*^*mTmG/mTmG*^Ubiquitous[@CR113]+++Fluorescent signals are detectable; useful*Cd11c*^*DTR-GFP/+*^Dendritic cells[@CR114]+Fluorescent signals are hardly detectable*Cd11c*^*Cre/+*^*;R26*^*EYFP/+*^Dendritic cells, alveolar macrophages[@CR112],[@CR115]+Fluorescent signals are hardly detectable*Cd11c*^*Cre/+*^*;R26*^*tdTomato/+*^Dendritic cells, alveolar macrophages[@CR42],[@CR115]+++Fluorescent signals are detectable; useful*Cd11c*^*Cre/+*^*;R26*^*mTmG/+*^Dendritic cells, alveolar macrophages (mGFP); ubiquitous other than dendritic cells and alveolar macrophages (mTomato)[@CR113],[@CR115]+++ (mGFP) ++ (mTomato)Fluorescent signals are detectable; useful*Zbtb46*^*GFP/GFP*^Dendritic cells, endothelial cells[@CR116]+Fluorescent signals are hardly detectable*Zbtb46*^*Cre/+*^*;R26*^*tdTomato/+*^Dendritic cells, endothelial cells[@CR42],[@CR117]++++Because the fluorescence signal of the endothelial cells is very strong, a bone marrow chimera is needed for immune cell observations*Zbtb46*^*Cre/+*^*;R26*^*mTmG/+*^Dendritic cells, endothelial cells[@CR113],[@CR117]++++ (mGFP) ++ (mTomato)Because the fluorescence signal of the endothelial cells is very strong, a bone marrow chimera is needed for immune cell observations*Clec9a*^*GFP/+*^Dendritic cells[@CR118]+Fluorescent signals are hardly detectable*Csf1r*^*GFP/+*^Macrophages[@CR119]+++Because many cells are fluorescently labeled, it is difficult to make cell-specific observations, especially in infected lung*Cx3cr1*^*GFP/+*^Macrophages, monocytes[@CR120]+++Fluorescent signals are detectable; useful*Cx3cr1*^*Cre/+*^*;R26*^*tdTomato/+*^Macrophages, monocytes[@CR42],[@CR121]++++Because many cells are fluorescently labeled, it is difficult to make cell-specific observations, especially in infected lung*Cx3cr1*^*CreER/+*^*;R26*^*tdTomato/+*^Macrophages, monocytes[@CR42],[@CR121]+++Fluorescent signals are detectable; useful*LysM*^*GFP/+*^Neutrophils, macrophages[@CR30]+++Because many cells are fluorescently labeled, it is difficult to make cell-specific observations, especially in infected lung*Ly6g*^*Cre/+*^*;R26*^*tdTomato/+*^ (Catchup^IVM-red^)Neutrophils[@CR32],[@CR42]+++Fluorescent signals are detectable; useful*Ly6g*^*Cre/+*^*;R26*^*mTmG/+*^Neutrophils (mGFP); ubiquitous other than neutrophils (mTomato)[@CR32],[@CR113]+++ (mGFP) ++ (mTomato)Fluorescent signals are detectable; useful*Ly6g*^*Cre/+*^*;R26*^*mTFP1/+*^Neutrophils[@CR32],[@CR33]+++Fluorescent signals are detectable; useful*Ly6g*^*Cre/+*^*;R26*^*tdTomato/+*^*;Cx3cr1*^*GFP/+*^Macrophages, monocytes (GFP); neutrophils (Tomato)[@CR32], [@CR42],[@CR120]+++ (GFP) +++ (Tomato)Fluorescent signals are detectable; useful*Cd4*^*CreER/+*^*;R26*^*tdTomato/+*^CD4T lymphocytes[@CR42],[@CR122]+++Fluorescent signals are detectable; useful*Cd4*^*CreER/+*^*;R26*^*mTmG/+*^CD4T lymphocytes (mGFP); ubiquitous other than CD4T lymphocytes (mTomato)[@CR113],[@CR122]+++ (mGFP) ++ (mTomato)Fluorescent signals are detectable; useful*Cd8a*^*Cre/+*^*;R26*^*tdTomato/+*^CD8T lymphocytes[@CR42],[@CR123]+++Fluorescent signals are detectable; useful*Cd8a*^*Cre/+*^*;R26*^*mTFP1/+*^CD8T lymphocytes[@CR33],[@CR123]+++Fluorescent signals are detectable; useful*Cd19*^*Cre/+*^*;R26*^*tdTomato/+*^B lymphocytes[@CR42],[@CR124]+++Fluorescent signals are detectable; useful*Mcpt8*^*Cre/+*^*;R26*^*tdTomato/+*^Basophils[@CR42],[@CR125]+++Fluorescent signals are detectable; useful*Ncr1*^*GFP/+*^NK cells[@CR126]++Fluorescent signals are detectable; useful*Sftpc*^*CreER/+*^*;R26*^*tdTomato/+*^Type II pneumocytes[@CR31],[@CR42]++++Fluorescent signals are detectable; useful*Sftpc*^*CreER/+*^*;R26*^*mTmG/+*^Type II pneumocytes (mGFP); ubiquitous other than Type II pneumocytes (mTomato)[@CR31],[@CR113]+++ (mGFP) ++ (mTomato)Fluorescent signals are detectable; useful*Sftpc*^*CreER/+*^*;R26*^*tdTomato/+*^*;Cx3cr1*^*GFP/+*^Macrophages, monocytes (GFP); Type II pneumocytes (Tomato)[@CR31], [@CR42],[@CR120]+++ (GFP) ++++ (Tomato)Fluorescent signals are detectable; useful*Sftpc*^*GFP/+*^Type II pneumocytes[@CR127]++++Fluorescent signals are detectable; usefulThe brightness of each fluorescent protein during in vivo lung imaging was scored as relative fluorescence intensity compared with FluoSpheres fluorescent microspheres as an internal standard. For relative intensities of 0--0.2, 0.2--0.6, 0.6--0.9, and \>0.9, the brightness scores are represented as +, ++, +++, and ++++, respectively.Table 3Comparison of fluorescent reporter viruses (Color-flu) for in vivo imaging using two-photon excitation microscopyReporter proteinVirus nameTiterVolumeExcitation (nm)Emission (nm)BrightnesseCFPMA-eCFP-PR8 MA-eCFP-H5N110^5^ PFU50 μl910477+CeruleanMA-Cerulean-PR8 MA-Cerulean-H5N110^5^ PFU50 μl910475+++eGFPMA-eGFP-PR8 MA-eGFP-H5N110^5^ PFU50 μl910507+++VenusMA-Venus-PR8 MA-Venus-H5N110^5^ PFU50 μl910528+++mCherryMA-mCherry-PR8 MA-mCherry-H5N110^5^ PFU50 μl910610+The brightness of each fluorescent protein during in vivo lung imaging was scored as relative fluorescence intensity compared with FluoSpheres fluorescent microspheres as an internal standard. For relative intensities of 0--0.2, 0.2--0.6, 0.6--0.9, and \>0.9, the brightness scores are represented as +, ++, +++, and ++++, respectively.**Caution**All relevant guidelines regarding the use of animals and recombinant viruses should be followed.**Critical**Fluorescent reporter influenza viruses (Color-flu) stably express high levels of a reporter protein in the infected cells and show comparable virulence to those of wild-type influenza viruses in mice^[@CR25]^. Depending on the experiments, modify the virus infectious dose, monitor the infected mice in the days following infection, and determine the appropriate time point for observation (e.g., when mice are infected with 10^3^ PFU of MA-Venus-PR8, infected cells can be observed for up to 7 d post-infection). Of note, infected cells may not be observed if the infectious dose is too low.**Critical**As controls for the experiment, use wild-type mice or transgenic mice that are not infected with influenza virus and administer the same fluorescently labeled antibodies and reagents as those used in the test group.

Starting up the imaging system equipment {#Sec36}
----------------------------------------

Timing 20--30 min2On the day of analysis, turn on the two-photon excitation laser and the Aligna 4D control unit placed outside the BSL3 facility, and verify that they are working.**Critical**The Aligna 4D control unit needs to be kept ON.3Wearing a Tyvek suit, positive pressure mask, and gloves according to the guidelines for the BSL3 facility, enter the BSL3 facility where the imaging system is housed.[Troubleshooting](#Sec44){ref-type="sec"}4Turn on the microscope controllers, confocal lasers, and the computer for the two-photon excitation microscope and the Aligna 4D system.5Launch the microscope control software ZEN and turn on the lasers, including the two-photon excitation laser.6Launch the Aligna 4D control software Kangoo and adjust the laser path connecting the laser source unit and the microscope (Supplementary Fig. [4](#Fig10){ref-type="supplementary-material"}).[Troubleshooting](#Sec44){ref-type="sec"}7Wrap the hot plate with aluminum foil, turn it on, and keep it at 35 °C. Sterilize the surgical area and tools with 70% ethanol and place all instruments within easy reach.

Animal anesthesia {#Sec37}
-----------------

Timing 2--3 min8Turn on the gas anesthesia vaporizer and supply 5% isoflurane to a mouse anesthesia induction chamber.9Anesthetize the influenza virus--infected mouse with 5% isoflurane in a mouse anesthesia induction chamber. Subsequently, transfer the mouse to the hot plate while supplying 2% isoflurane via an anesthetic mask.[Troubleshooting](#Sec44){ref-type="sec"}

Administration of fluorescent dyes {#Sec38}
----------------------------------

Timing 5 min10Inject the chosen fluorescent dyes and antibodies via the retro-orbital plexus (as shown in Supplementary Video [1](#MOESM3){ref-type="media"}) using an insulin syringe. Tables [4](#Tab4){ref-type="table"} and [5](#Tab5){ref-type="table"} show the brightness levels of antibodies and fluorescence of dyes, respectively, in vivo.Table 4Comparison of fluorochrome-conjugated antibodies for in vivo imaging using two-photon excitation microscopyFluorochromeProduct nameCat. no.CloneConcentrationVolumeExcitation (nm)Emission (nm)BrightnessFITCFITC-conjugated anti-mouse Ly-6G antibody127606, BioLegend1A8100 μg/ml50 μl910519+AF 488AF 488--conjugated anti-mouse Ly-6G antibody127626, BioLegend1A8100 μg/ml50 μl910519+Dy Light 488DyLight 488--conjugated anti-mouse Ly-6G antibodyL287, Leinco Technologies1A8100 μg/ml50 μl910518+PEPE-conjugated anti-mouse Ly-6G antibody551461, BD Biosciences1A8100 μg/ml50 μl910578+++AF 594AF 594--conjugated anti-mouse Ly-6G antibody127636, BioLegend1A8100 μg/ml50 μl910617++AF 647AF 647--conjugated anti-mouse Ly-6G antibody127610, BioLegend1A8100 μg/ml50 μl910668NDThe brightness of each fluorochrome during in vivo lung imaging was scored as relative fluorescence intensity compared with FluoSpheres fluorescent microspheres as an internal standard. For relative intensities of 0--0.2, 0.2--0.6, 0.6--0.9, and \>0.9, the brightness scores are represented as +, ++, +++, and ++++, respectively. AF, Alexa Fluor; ND, not detected.Table 5Comparison of fluorescent dyes for in vivo imaging using two-photon excitation microscopyDyeTargetCat. no.ConcentrationVolumeExcitation (nm)Emission (nm)BrightnessDextran Cascade Blue, 10,000 MW, lysine fixableBlood flowD1976, Invitrogen25 mg/ml50 μl910420NDFluorescein isothiocyanate--dextran average MW 4,000Blood flow46944, Sigma-Aldrich2 mg/ml50 μl910519+++Dextran fluorescein, 10,000 MW, lysine fixableBlood flowD1820, Invitrogen2 mg/ml50 μl910519+++Dextran fluorescein, 40,000 MW, lysine fixableBlood flowD1845, Invitrogen2 mg/ml50 μl910519+++Fluorescein isothiocyanate--dextran, average MW 70,000Blood flow46945, Sigma-Aldrich2 mg/ml50 μl910519+++Dextran Texas Red, 3,000 MW, lysine fixableBlood flowD3328, Invitrogen2 mg/ml50 μl910615+++Dextran Texas Red, 10,000 MW, lysine fixableBlood flowD1863, Invitrogen2 mg/ml50 μl910615+++Dextran Texas Red, 70,000 MW, lysine fixableBlood flowD1864, Invitrogen2 mg/ml50 μl910615+++Qtracker 655 vascular labelsBlood flowQ21021MP, Invitrogen0.1 μM50 μl910655+++FluoSpheres fluorescent microspheres for tracer studiesBlood flow velocityF-13083, Molecular Probes1 × 10^8^ beads/ml50 μl910605++++Qdot 655 WGAWhole cellsQ12021MP, Invitrogen×2050 μl910655+Calcein AM solutionLive cellsC1359, Sigma-Aldrich100 μM50 μl910520NDSYTOX Blue nucleic acid stainDead cellsS11348, Invitrogen50 μM50 μl910480+++SYTOX Green nucleic acid stainDead cellsS7020, Invitrogen50 μM50 μl910523+++SYTOX Orange nucleic acid stainDead cellsS11368, Invitrogen50 μM50 μl910570+++Propidium iodide nucleic acid stainDead cellsP1304MP, Invitrogen1 mM50 μl910617++++DAPI nucleic acid stainDead cellsD3571, Invitrogen10 mM50 μl910461NDHoechst 33342NucleiH3570, Invitrogen10 mg/ml50 μl910461++Cas-MAP Green in vivo fluorescent imaging probesApoptotic cells20100, Vergent Bioscience×160 μl910533NDPKH26 Red Fluorescent Cell Linker Kit for Phagocytic Cell LabelingPhagocytic cellsPKH26PCL, Sigma-Aldrich10 μM50 μl (intranasal administration)910567+++CellROX Green ReagentOxidative stressC10444, Molecular Probes250 μM50 μl910520+++CellROX Orange ReagentOxidative stressC10443, Molecular Probes250 μM50 μl910565+++CellRox Deep RedOxidative stressC10422, Molecular Probes250 μM50 μl910665+LysoTracker Blue DND-22LysosomesL7525, Molecular Probes100 μM50 μl910422NDLysoTracker Green DND-26LysosomesL7526, Molecular Probes100 μM50 μl910511+++LysoTracker Red DND-99LysosomesL7528, Molecular Probes100 μM50 μl910590++LysoTracker Deep RedLysosomesL12492, Molecular Probes100 μM50 μl910668++MitoTracker Orange CMTMRosMitochondriaM7510, Invitrogen100 μM50 μl910576+++MitoTracker CM-H~2~XrosMitochondriaM7513, Invitrogen100 μM50 μl910599+++MitoTracker Red FMMitochondriaM22425, Invitrogen100 μM50 μl910644++Rhodamine 6GMitochondria252433, Sigma-Aldrich10 μM50 μl910555+++TMREMitochondriaT669, Invitrogen1 mM50 μl910575+++SiR-actinActinCY-SC001, SPIROCHROME100 μM50 μl940674+SiR-tubulinTubulinCY-SC002, SPIROCHROME100 μM50 μl940674NDThe brightness of each fluorochrome during in vivo lung imaging was scored as relative fluorescence intensity compared with FluoSpheres fluorescent microspheres as an internal standard. For relative intensities of 0--0.2, 0.2--0.6, 0.6--0.9, and \>0.9, the brightness scores are represented as +, ++, +++, and ++++, respectively. ND, not detected.**Caution**When working with viruses in a BSL3 containment, it is not safe to use needles, so we avoid them as much as possible, which is a standard precaution in high-containment laboratories. In addition, in the BSL3 facility, animal experiments must be performed wearing two or three layers of latex gloves. Tail-vein administration is a common method; however, it is not easy to perform these procedures with so many layers of gloves. Use tweezers to hold down the mouse to make the administration route. When an infected animal is not used, an administration route can be created via the tail vein or the jugular vein.

Surgical procedure {#Sec39}
------------------

Timing 10--15 min

### Critical {#FPar24}

Before experimenting with infected animals, practice the surgical procedures with euthanized animals.

11Place the mouse on its back and tape the anterior limbs with adhesive tape (Fig. [4a](#Fig4){ref-type="fig"}).Fig. 4Surgical procedure for lung imaging.**a**, Place the mouse on its back and tape with adhesive tape. **b**, Cut the skin beneath the chin and expose the trachea. **c**, Insert a tracheal cannula. **d**, Place the mouse in the right lateral decubitus position. **e**, Make an incision in the skin at the left axilla. **f**, Expose the left lung lobe and keep it exposed by using retractors. **g**, Lower the thoracic suction window gently to immobilize the lungs of the mouse. **h**, Close-up of the thoracic suction window. **i**, Lower the objective lens to the thoracic suction window. All our animal care and experiments conformed to the guidelines for animal experiments of the University of Tokyo and were approved by the animal research committee of the University of Tokyo (PA17-31 and PA17-17).12Using straight scissors, cut the skin beneath the chin in the middle and expose the trachea (Fig. [4b](#Fig4){ref-type="fig"}). Insert a tracheal cannula and intubate the mouse to facilitate mechanical ventilation with a ventilator (Fig. [4c](#Fig4){ref-type="fig"}). Turn on the ventilator, ventilate the mouse at a respiratory rate of 120 breaths per min, and apply positive-end expiratory pressure (PEEP; \~6 cm H~2~O) and a tidal volume of \~0.5 mL. Deliver isoflurane continuously at 2% to maintain anesthesia.**Caution**Perform the surgery with care so as not to cut the blood vessels. If bleeding occurs, stop the bleeding with fine bulldog forceps for microsurgery.13Place the mouse in the right lateral decubitus position and re-fix its anterior limbs with the tape (Fig. [4d](#Fig4){ref-type="fig"}). Make an incision in the skin at the left axilla using straight scissors, straight iris scissors, and hooked forceps (Fig. [4e](#Fig4){ref-type="fig"}).**Caution**Carefully change the mouse's position in order to avoid cannula drop off.14Expose the left lung lobe by surgical intercostal incision between ribs 3 and 4, and keep it exposed by using retractors (Fig. [4f](#Fig4){ref-type="fig"}).**Caution**Perform the surgery with care so as not to cut the blood vessels. If bleeding occurs, stop the bleeding with fine bulldog forceps for microsurgery.**Critical**Because lungs infected with viruses often shrink, secure a large field of surgical view so that the suction window can reach it.15Place the mouse beneath the objective lens and connect a device to monitor the heart rate of the mouse (we use a LabOx-1 pulse oximeter).[Troubleshooting](#Sec44){ref-type="sec"}

Starting up the thoracic vacuum window system {#Sec40}
---------------------------------------------

Timing 2--3 min16Turn on the aspirator connected to the thoracic suction window.17Fix the thoracic suction window to the holding block at a 90° angle and put a round cover glass on the tip of the suction device.[Troubleshooting](#Sec44){ref-type="sec"}18Turn on the suction pressure regulator and adjust the suction pressure to 25--30 mmHg.

Observation of lungs infected with influenza viruses {#Sec41}
----------------------------------------------------

Timing 2--3 min19Lower the thoracic suction window gently to immobilize the mouse lungs (Fig. [4g,h](#Fig4){ref-type="fig"}). The thoracic suction window should cause the lung to stick to the cover glass because of negative pressure.**Caution**Carefully move the suction window so as not to scratch the objective.20Position the objective lens above the thoracic window.21Put water drops on the cover glass by using a pasteur pipette and lower the objective lens to the thoracic suction window (Fig. [4i](#Fig4){ref-type="fig"}).22Double-check the general condition of the mouse and its position.

Data acquisition {#Sec42}
----------------

Timing 1--4 h per sample23Acquire images using the lambda mode of the ZEN software. Record time series at different frequencies according to need.

Unmixing of spectrum data and analyzing the images {#Sec43}
--------------------------------------------------

Timing 1--2 h per sample24To unmix the spectrum data, prepare a reference image of each spectrum in advance. To make a reference image, acquire each fluorescent dye or protein separately without any co-staining and analyze the single fluorescent spectrum. We use the linear unmixing module of the ZEN software for separating spectrum data; however, other commercial or open-source software is available (Table [6](#Tab6){ref-type="table"}).Table 6Open-source packages for image processing and analysesPurposeSoftwareResourceFeaturesRef.Unmixing of lambda image stackHyper-Spectral Phasors<https://www.nature.com/articles/nmeth.4134>Windows/macOS executable[@CR128]Orfeo ToolBox<https://www.orfeo-toolbox.org/>Windows/macOS/Linux executable[@CR129]Spectral Unmixing Plugins<https://imagej.nih.gov/ij/plugins/spectral-unmixing.html>ImageJ plugin[@CR130],[@CR131]PoissonNMF<https://neherlab.org/poisson_nmf_overview.html>ImageJ plugin[@CR132]Respiratory artifact correctionImregdemons (image-processing toolbox for MATLAB)<https://www.mathworks.com/help/images/ref/imregdemons.html>MATLAB function[@CR133],[@CR134]Automatic image reconstructionAlgorithm described in the original paperAlgorithm[@CR135]Intravital microscopy artifact reduction tool (IMART)<http://www.medicine.iupui.edu/icbm/software/>MATLAB executable[@CR136],[@CR137]Intravital Microscopy Toolbox10.1371/journal.pone.0053942.s020 or <http://stevelacroix.crchudequebec.ca/support-visuel_en.php>ImageJ macro[@CR138]Galene<https://galene.flimfit.org/>Windows/macOS executable[@CR139]Single-cell trackingThe Tracking Tool (tTt)<https://www.nature.com/articles/nbt.3626>Windows/macOS executable[@CR140]CellProfiler<https://cellprofiler.org/>Windows/macOS executable[@CR141]Icy<http://icy.bioimageanalysis.org/>Java application[@CR142]TrackMate<http://fiji.sc/TrackMate>ImageJ plugin[@CR34]25Subject unmixed time-series stacks to image registration to correct for tissue drifts and respiratory artifacts. This step is critical to certain analyses, such as long-term tracking of individual cells or subcellular structures. In some cases, a reference channel is required for determining the shift and distortion of the objects. In our studies, we use time-series stacks of blood vessels or collagens for such use, because their localizations are constant over time without substantial changes in shape or structure during the observation.**Caution**Some image registration algorithms may cause spatial distortion. Choose algorithms that generate corrected data suitable for your subsequent analyses, especially when examination of the shape and structure of cells and tissues is required.26Analyze the movies as required for your experiment.

Troubleshooting {#Sec44}
===============

Troubleshooting advice can be found in Table [7](#Tab7){ref-type="table"}.Table 7Troubleshooting tableStepProblemPossible reasonSolution3Difficulty handling mice in BSL3 facilityNormal gloves are not suitable for working in a BSL3 facilitiesTo perform detailed work in a BSL3 facility, the outermost gloves should be surgical gloves that match the size of your hand6No laser signal on the Aligna 4D control softwareLaser switch is offMake sure that the laser switch is turned on with the main unit and the ZEN software9Mice die during anesthesiaThe level of anesthesia is too highDecrease the concentration of anesthesia as soon as the mouse shows loss of righting reflex10Mice regain consciousness during anesthesiaThe level of anesthesia is too lowConfirm the concentration of anesthesia; administer the reagents again after a brief pause15No heart rate is measuredThe monitoring probe is mispositionedMake sure that the monitoring probe is in the appropriate place17The cover glass falls offThe cover glass does not hold on the suction devicePut water droplets on the tip of the suction device and then place the cover glass on it

Timing {#Sec45}
======

Step 1, infection: 10--20 minSteps 2--7, starting up the imaging system equipment: 20--30 minSteps 8--22, anesthesia and surgical preparation for imaging: 21--29 minSteps 23--26, data acquisition and image analyses: 2--6 h per sample (depending on the number of samples, fluorescent colors, and acquired frames)

Anticipated results {#Sec46}
===================

The imaging system described in this protocol enables the observation of the behavior of virus-infected cells and immune cells in infected lungs in real time. Typical images of influenza virus--infected lung are shown in Fig. [5a](#Fig5){ref-type="fig"} and Supplementary Video [2](#MOESM4){ref-type="media"}. When observing while using a multicolor fluorescent label, it is easier to analyze the detected images if the brightness level of each fluorophore is adjusted to make them similar. It is better to choose fluorescent dyes or proteins that possess high fluorescence stability for long-term observations (Tables [2](#Tab2){ref-type="table"}, [4](#Tab4){ref-type="table"} and [5](#Tab5){ref-type="table"}). We have found that use of MA-Cerulean-viruses or MA-Venus-viruses for infection produces influenza virus--infected cells with sufficient brightness (Table [3](#Tab3){ref-type="table"}). For labeling immune cells and alveolar cells, we have achieved good results by using the fluorochrome phycoerythrin (PE) for antibody staining and Rosa-tdTomato^[@CR42]^ or -mTFP1^[@CR33]^ mice that were crossed with cell-specific Cre-expressing mice. If using reporter mice expressing a fluorescent protein such as GFP, which is regulated by an endogenous promoter, the expression level of the fluorescent protein should be confirmed. To visualize the lung structure, we use Texas-Red dextran or Qtracker 655 Vascular Labels for the red to far-infrared channel.Fig. 5In vivo multicolor imaging of influenza virus--infected lungs.**a**, Catchup^IVM-red^ mice were intranasally infected with 10^5^ PFU of MA-Venus-H5N1 or MA-Venus-PR8 virus and observed at 4 d post-infection. Fluorescent dextran (blue) was intravenously administered to visualize the lung architecture. Red and green indicate neutrophils and virus-infected cells, respectively. **b**, *Ly6g*^*Cre/+*^*;R26*^*mTFP1/+*^ mice were intranasally infected with 10^5^ PFU of MA-Venus-PR8 virus and observed at 7 d post-infection. PE-conjugated anti-mouse Ly-6G antibody (red) and fluorescent dextran (white) were intravenously administered to visualize the vascular neutrophils and lung architectures, respectively. Green indicates virus-infected cells. Blue indicates both infiltrating (arrowheads) and vascular neutrophils (arrow). **c**, *Ly6g*^*Cre/+*^*;R26*^*tdTomato/+*^*;Cx3cr1*^*GFP/+*^ mice were intranasally infected with 10^5^ PFU of MA-Venus-PR8 virus and observed at 5 d post-infection. Fluorescent dextran (white) was intravenously administered to visualize the lung architecture. Red, green, and blue indicate neutrophils, monocytes, and virus-infected cells, respectively. The yellow arrowhead and arrow indicate a neutrophil and a monocyte, respectively, in contact. AB, antibody.

Influenza virus--infected lungs are infiltrated by numerous immune cells, including neutrophils and monocytes^[@CR43]--[@CR45]^. An immune cell--specific reporter mouse line can be used to visualize cells infiltrating the alveoli and cells in blood vessels, whereas it is preferable to label intravascular cells by intravenous administration of fluorochrome-conjugated antibodies^[@CR5],[@CR46],[@CR47]^. Consistent with previous reports, intravenously injected antibodies will label only the cells in contact with the blood flow and not those in extravascular regions under our experimental conditions^[@CR5]^. By administering a fluorescently labeled antibody against neutrophils into neutrophil reporter mice, we can observe the behavior of both the neutrophils infiltrating the influenza-infected lungs and the neutrophils in blood vessels separately (Fig. [5b](#Fig5){ref-type="fig"}). To observe the interaction between different kinds of infiltrating immune cells, such as neutrophils and monocytes, double-reporter mice expressing fluorescent proteins with different spectra but similar brightness have a major advantage (Fig. [5c](#Fig5){ref-type="fig"} and Supplementary Video [3](#MOESM5){ref-type="media"}).

Co-infection of the host with different strains of influenza virus can lead to the emergence of reassortant viruses. By infecting mice with Color-flu viruses that produce different fluorescence spectra, we detected alveolar epithelial cells that simultaneously expressed two fluorescent proteins in vivo (Fig. [6](#Fig6){ref-type="fig"}). Visualization of co-infected cells might enable us to better understand the reassortment process of influenza viruses in vivo.Fig. 6Co-infection imaging of influenza virus--infected lungs.B6 mice were intranasally infected with 10^5^ PFU of MA-Venus-H5N1 and MA-Cerulean-H5N1, or MA-Venus-PR8 and MA-Cerulean-PR8 viruses and observed at 3 d (H5N1) or 4 d (PR8) post-infection. Fluorescent dextran (white) was intravenously administered to visualize the lung architecture. Red and green indicate MA-Cerulean-virus-infected cells (yellow arrows) and MA-Venus-virus-infected cells (white arrows), respectively. The yellow arrowheads indicate cells co-infected with MA-Cerulean-virus and MA-Venus-virus. Scale bar, 50 µm.

In summary, the use of this in vivo imaging system for infected animal and multicolor imaging enables us to analyze pathology and immune cell dynamics at the cellular level, which would not be possible by using conventional histopathology methods. This imaging system thus provides a novel and useful approach for investigating viral pathogenicity.

Reporting Summary {#Sec47}
-----------------

Further information on research design is available in the [Nature Research Reporting Summary](#MOESM2){ref-type="media"} linked to this article.
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Supplementary Figure 1Comparison of the changes in the autofluorescence signal depending on the excitation laser power.Lungs of C57BL/6 mice were observed by using a two-photon excitation microscope with the excitation laser set at 910 nm. The numbers in the panel indicate the laser power. Blue indicates second-harmonic generation (SHG). Red and green indicate autofluorescence at different fluorescent wavelengths. Scale bar, 50 µm.

Supplementary Figure 2Comparison of the changes in the autofluorescence signal depending on the excitation laser wavelength.Lungs of C57BL/6 mice were observed by using a two-photon excitation microscope with the excitation laser set at the indicated wavelength. The numbers in the panel indicate the laser power. Blue and red indicate autofluorescence at different fluorescent wavelengths. Scale bar, 50 µm.

Supplementary Figure 3Design drawing and production procedure of the thoracic suction window.**a**. i) Cut a brass round bar (Φ50) to a thickness of 3 mm, drill a hole (φ4) in the center, and make a scoop with a depth of 0.7 mm (R20) in the center by using an NC lathe. ii) Trim away a 0.5-mm-deep portion of the round plate. iii) Cut off the part indicated in the figure (width 20.7 mm). iv) Cut off the part indicated in the figure (width 21 mm). v) Cut off the opposite part indicated in the figure (width 21 mm). vi) Cut off both sides at 1 mm ×20.8 mm. vii) Make a round groove (5 mm deep) by using a circular table. viii) Create 90- and 45-degree grooves with a ball end mill. ix) Make a hole at Φ1. **b**. i) Cut a round brass bar (Φ8) to 80 mm in length. ii) Trim away one side of the round bar (0.5 mm). iii) Drill a hole to a depth of 60 mm. iv) Make an M5 screw hole 8 mm in depth. v) Make a hole (Φ1) from the opposite side. vi) Cut off the part indicated in the figure. **c**. i) Solder piece **a** and piece **b**. ii) Smooth the thoracic window with a file. iii) Plate the thoracic window with nickel chrome.

Supplementary Figure 4Operation of the laser path compensation software.**a**. Initial screen. **b**. Make sure the laser is switched on, and turn on the AutoGain button (yellow arrow). **c**. Turn on the RegOn button (yellow arrow). **d**. Make sure that the beam angle and beam position overlap at the center of the screen (yellow arrow). Some images provided courtesy of Coherent and Zeiss.

Supplementary information
-------------------------

Supplementary InformationSupplementary Figs. 1--4. Reporting Summary Supplementary Video 1Administration of fluorescent reagents via the retro-orbital plexus. Supplementary Video 2In vivo imaging of mouse lung infected with influenza viruses. Supplementary Video 3Multicolor imaging of neutrophil and monocyte dynamics in influenza virus--infected lungs.
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